Bone-scan-like pattern with tcm(v)-dmsa scintigraphy in patients with osteomalacia and primary hyperparathyroidism

Nuclear Medicine Communications

Volumn 21, Issue 2, 2000, Pages 181-185

  Akbunar, A T ^a   Orhan, B ^a   Alper, E ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE; FEMALE; HUMAN; HYPERPARATHYROIDISM; MIDDLE AGED; OSTEOMALACIA; SCINTISCANNING; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; BONE AND BONES; FEMALE; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; OSTEOMALACIA; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TECHNETIUM TC 99M MEDRONATE; TISSUE DISTRIBUTION;

EID: 0034137566     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200002000-00010     Document Type: Article

References (13)

1. Frame B, Parfitt M. Osteomalacia: Current concepts. Ann Intern Med 1978; 89: 966-982.
2. Francis RM, Selby PL. Osteomalacia. Ballières Clin Endocrinol Metab 1997; 11: 145-163.
3. Strewler GJ. Mineral metabolism and metabolic bone disease. In: Greenspan FS, Strewler GJ, eds. Basic and clinical endocrinology, 5th edn. Stamford, CT: Appleton & Lange, 1997: 263-316.
4. Binghom CT, Fitzpatrick LA. Noninvasive testing in the diagnosis of osteomalacia. Am J Med 1993; 95: 519-523.
5. Hirano T, Otake H, Yoshida I, Endo K. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA. J Nucl Med 1995; 36: 202-207.
6. Hirano T, Otake H, Kazama K et al. Technetium-99m(V)DMSA and thallium-201 in brain tumor imaging: Correlation with histology and malignant grade. J Nucl Med 1997; 38: 1741-1749.
7. Ugur O, Kostakoglu L, Guler N et al. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 1996; 23: 1367-1371.
8. Kobayashi H, Sakahara H, Hosono M et al. Soft tissue tumors: Diagnosis with Tc-99m(V)-dimercaptosuccinic acid scintigraphy. Radiology 1994; 190: 277-280.
9. Ercan MT, Gulaldi NC, Unsal IS, Aydin M, Peksoy I, Hascelik Z. Evaluation of Tc-99m(V)-DMSA for imaging inflammatory lesions: An experimental study. Ann Nucl Med 1996; 10: 419-423.
10. Higuchi T, Hirano T, Inoue T et al. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy. J Nucl Med 1998; 39: 541-543.
11. Lam AS, Kettle AG, O'Doherty MS, Coakley AJ, Barrington SF, Blower PJ. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases. Nucl Med Commun 1997; 18: 907-914.
12. Lam ASK, Puncher MRB, Blower PJ. In vitro and in vivo studies with pentavalent technetium-99m-dimercaptosuccinic acid. Eur J Nucl Med 1996; 23: 1575-1582.
13. Masiukiewicz US, Insogna KL. The role of parathyroid hormone in the pathogenesis, prevention and treatment of postmenopausal osteoporosis. Aging 1998; 10: 232-239.